201 related articles for article (PubMed ID: 12675312)
21. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
Stapleton SL; Reid JM; Thompson PA; Ames MM; McGovern RM; McGuffey L; Nuchtern J; Dauser R; Blaney SM
Cancer Chemother Pharmacol; 2007 Mar; 59(4):461-6. PubMed ID: 16855840
[TBL] [Abstract][Full Text] [Related]
22. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
Neville K; Parise RA; Thompson P; Aleksic A; Egorin MJ; Balis FM; McGuffey L; McCully C; Berg SL; Blaney SM
Clin Cancer Res; 2004 Apr; 10(7):2525-9. PubMed ID: 15073132
[TBL] [Abstract][Full Text] [Related]
23. Metabolic activation of temozolomide measured in vivo using positron emission tomography.
Saleem A; Brown GD; Brady F; Aboagye EO; Osman S; Luthra SK; Ranicar AS; Brock CS; Stevens MF; Newlands E; Jones T; Price P
Cancer Res; 2003 May; 63(10):2409-15. PubMed ID: 12750260
[TBL] [Abstract][Full Text] [Related]
24. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
[TBL] [Abstract][Full Text] [Related]
25. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
Scott-Moncrieff JC; Chan TC; Samuels ML; Cook JR; Coppoc GL; DeNicola DB; Richardson RC
Cancer Chemother Pharmacol; 1991; 29(1):13-8. PubMed ID: 1742843
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors.
Panetta JC; Kirstein MN; Gajjar A; Nair G; Fouladi M; Heideman RL; Wilkinson M; Stewart CF
Cancer Chemother Pharmacol; 2003 Dec; 52(6):435-41. PubMed ID: 13680158
[TBL] [Abstract][Full Text] [Related]
27. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates.
Blaney SM; Takimoto C; Murry DJ; Kuttesch N; McCully C; Cole DE; Godwin K; Balis FM
Cancer Chemother Pharmacol; 1998; 41(6):464-8. PubMed ID: 9554590
[TBL] [Abstract][Full Text] [Related]
28. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.
Berg SL; Aleksic A; McGuffey L; Dauser R; Nuchtern J; Bernacky B; Blaney SM
Cancer Chemother Pharmacol; 2004 Aug; 54(2):127-30. PubMed ID: 15150671
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
Diez BD; Statkevich P; Zhu Y; Abutarif MA; Xuan F; Kantesaria B; Cutler D; Cantillon M; Schwarz M; Pallotta MG; Ottaviano FH
Cancer Chemother Pharmacol; 2010 Mar; 65(4):727-34. PubMed ID: 19641919
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
[TBL] [Abstract][Full Text] [Related]
31. High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma.
Kim H; Likhari P; Parker D; Statkevich P; Marco A; Lin CC; Nomeir AA
J Pharm Biomed Anal; 2001 Jan; 24(3):461-8. PubMed ID: 11199225
[TBL] [Abstract][Full Text] [Related]
32. The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.
Marcus L; Murphy R; Fox E; McCully C; Cruz R; Warren KE; Meyer T; McNiff E; Balis FM; Widemann BC
Cancer Chemother Pharmacol; 2012 Jan; 69(1):247-52. PubMed ID: 21706317
[TBL] [Abstract][Full Text] [Related]
33. A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients.
Rosso L; Brock CS; Gallo JM; Saleem A; Price PM; Turkheimer FE; Aboagye EO
Cancer Res; 2009 Jan; 69(1):120-7. PubMed ID: 19117994
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
Riccardi A; Mazzarella G; Cefalo G; Garrè ML; Massimino M; Barone C; Sandri A; Ridola V; Ruggiero A; Mastrangelo S; Lazzareschi I; Caldarelli M; Maira G; Madon E; Riccardi R
Cancer Chemother Pharmacol; 2003 Dec; 52(6):459-64. PubMed ID: 13680160
[TBL] [Abstract][Full Text] [Related]
35. Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.
Thompson PA; Berg SL; Aleksic A; Kerr JZ; McGuffey L; Dauser R; Nuchtern JG; Hausheer F; Blaney SM
Cancer Chemother Pharmacol; 2004 Jun; 53(6):527-32. PubMed ID: 14997342
[TBL] [Abstract][Full Text] [Related]
36. Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates.
Cho SY; Fox E; McCully C; Bauch J; Marsh K; Balis FM
Cancer Chemother Pharmacol; 2007 Sep; 60(4):563-7. PubMed ID: 17187251
[TBL] [Abstract][Full Text] [Related]
37. Temozolomide analogs with improved brain/plasma ratios - Exploring the possibility of enhancing the therapeutic index of temozolomide.
Rai R; Banerjee M; Wong DH; McCullagh E; Gupta A; Tripathi S; Riquelme E; Jangir R; Yadav S; Raja M; Melkani P; Dixit V; Patil U; Shrivastava R; Middya S; Olivares F; Guerrero J; Surya A; Pham SM; Bernales S; Protter AA; Hung DT; Chakravarty S
Bioorg Med Chem Lett; 2016 Oct; 26(20):5103-5109. PubMed ID: 27614414
[TBL] [Abstract][Full Text] [Related]
38. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
Berg SL; Stone J; Xiao JJ; Chan KK; Nuchtern J; Dauser R; McGuffey L; Thompson P; Blaney SM
Cancer Chemother Pharmacol; 2004 Jul; 54(1):85-8. PubMed ID: 15042312
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys.
Greene RF; Miser AW; Lester CM; Balis FM; Poplack DG
Pain; 1987 Sep; 30(3):339-348. PubMed ID: 3670879
[TBL] [Abstract][Full Text] [Related]
40. Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey.
Fox E; Bungay PM; Bacher J; McCully CL; Dedrick RL; Balis FM
J Pharmacol Exp Ther; 2002 Jun; 301(3):1003-11. PubMed ID: 12023531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
